Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 7701 - 7725 of 8960 in total
Caroxazone is an antidepressant that has been withdrawn from the market. It is a reversible monoamine oxidase inhibitor (MAOI) of both A and B monoamine oxidase subtypes. However, it presents a five-fold preference for the MAO-B subtype.
Withdrawn
Pavinetant has been used in trials studying the basic science and treatment of Safety and Schizophrenia.
Investigational
AZD6280 has been used in trials studying the basic science of Anxiety.
Investigational
AZD5423 has been used in trials studying the basic science and treatment of Asthma, Bioavailability and AUC, and Chronic Obstructive Pulmonary Disease (COPD).
Investigational
JNJ-39220675 has been used in trials studying the treatment of Allergic Rhinitis.
Investigational
Experimental
Matched Iupac: … .0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-3(24),4,6,8,10,12,14,16,18,20-decaen-4-yl]propanoic acid
Experimental
Matched Iupac: … .0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-3(24),4,6,8,10,12,14,16,18,20-decaen-4-yl]propanoic acid
9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide is an inactive derivative of the antitumour agents N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 9-amino-DACA.
Experimental
An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem]
Experimental
Investigational
Displaying drugs 7701 - 7725 of 8960 in total